Search research articles
联系我们
Search research articles
Search
相关实验视频
用于隔离Shigella的媒介.
J Bogaerts
,
P Lemmens
,
J Vandepitte
Lancet (London, England)
|
March 7, 1987
中文
概括
No abstract available in
PubMed
.
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
全部
12
Same author
6
Same journal
6
Same author
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.
ESMO open
·
2021
Same author
Toward a Reliable Evaluation of Forecasting Systems for Plant Diseases: A Case Study Using Fusarium Head Blight of Wheat.
Plant disease
·
2019
Same author
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2018
Same author
Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2018
Same author
Reply to the letter to the editor 'ESMO-MCBS v1.1: statistical and patient relevant shortcomings' by Emprechtinger et al.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2018
Same author
Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2017
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)
·
2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)
·
2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
查看所有相关文章